Nunzia Pharmaceutical Stock Working Capital
NUNZ Stock | USD 0 0.00 0.00% |
Nunzia Pharmaceutical fundamentals help investors to digest information that contributes to Nunzia Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Nunzia Pink Sheet. The fundamental analysis module provides a way to measure Nunzia Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nunzia Pharmaceutical pink sheet.
Nunzia |
Nunzia Pharmaceutical Company Working Capital Analysis
Nunzia Pharmaceutical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
Based on the company's disclosures, Nunzia Pharmaceutical has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The working capital for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
All Next | Launch Module |
Nunzia Fundamentals
Return On Asset | -2702.39 | |||
Current Valuation | 87.59 M | |||
Shares Outstanding | 434.52 M | |||
Shares Owned By Insiders | 81.95 % | |||
EBITDA | (9.02 M) | |||
Net Income | (9.02 M) | |||
Cash And Equivalents | 5.07 K | |||
Total Debt | 139.96 K | |||
Current Ratio | 0.20 X | |||
Cash Flow From Operations | (86.78 K) | |||
Earnings Per Share | (0.28) X | |||
Beta | -2.57 | |||
Market Capitalization | 24.88 M | |||
Total Asset | 5.13 K | |||
Net Asset | 5.13 K |
About Nunzia Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nunzia Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nunzia Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nunzia Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.